Regional and temporal differential regulation of the N-methyl-D-aspartate receptor by phencyclidine during development
dc.contributor.advisor | Kenneth M. Johnson, PhD. | en_US |
dc.contributor.committeeMember | Kathryn Cunningham, PhD. | en_US |
dc.contributor.committeeMember | Giulio Taglialatela, PhD. | en_US |
dc.contributor.committeeMember | Geoffrey T. Swanson | en_US |
dc.creator | Noelle Catherine Anastasio | en_US |
dc.date.accessioned | 2011-12-20T16:04:59Z | |
dc.date.accessioned | 2014-02-19T22:05:22Z | |
dc.date.available | 2008-06-17 | en_US |
dc.date.available | 2011-12-20T16:04:59Z | |
dc.date.available | 2014-02-19T22:05:22Z | |
dc.date.created | 2005-07-20 | en_US |
dc.date.issued | 2005-07-06 | en_US |
dc.description.abstract | Disruptions in glutamatergic neurotransmission may play a role in the pathogenesis of schizophrenia. The purpose of this study was to determine phencyclidine (PCP)-induced changes in the NMDA receptor subunit composition and the relationship of these changes to the deficits in pre-pulse inhibition (PPI) caused by PCP treatment. Postnatal rats were treated with atypical or typical antipsychotics or selective dopamine or serotonin receptor antagonists prior to acute or sub-chronic PCP. This study provides evidence that two distinct mechanisms underlie effects of acute and sub-chronic PCP on NMDA receptor subunit up-regulation. Furthermore, we discovered that D1, D2, and 5-HT2A receptors play a pivotal role in sub-chronic PCP-induced up-regulation of NR1 and NR2A. Finally, we were able to correlate changes in NMDA receptor subunits to the behavioral effects of PCP in this animal model of schizophrenia. | en_US |
dc.format.medium | electronic | en_US |
dc.identifier.other | etd-07202005-145246 | en_US |
dc.identifier.uri | http://hdl.handle.net/2152.3/170 | |
dc.language.iso | eng | en_US |
dc.rights | Copyright © is held by the author. Presentation of this material on the TDL web site by The University of Texas Medical Branch at Galveston was made possible under a limited license grant from the author who has retained all copyrights in the works. | en_US |
dc.subject | schizophrenia | en_US |
dc.subject | olanzapine | en_US |
dc.subject | animal model | en_US |
dc.title | Regional and temporal differential regulation of the N-methyl-D-aspartate receptor by phencyclidine during development | en_US |
dc.type.genre | thesis | en_US |
dc.type.material | text | en_US |
thesis.degree.department | Pharmacology and Toxicology | en_US |
thesis.degree.grantor | The University of Texas Medical Branch | en_US |
thesis.degree.level | Master | en_US |
thesis.degree.name | Master of Science | en_US |